Raj Tahil credits MIT with sparking his entrepreneurial instincts. “I learned to see problems as interesting opportunities,” says the president of Torpac Capsules, which specializes in custom capsules and pharmaceutical equipment. In the spirit of creating opportunities, Tahil and his spouse, Mary Jo Wrenn, have created an MIT donor-advised fund (DAF)—an increasingly popular way to simplify charitable giving.
The benefits of a DAF. An MIT DAF enables the donor to establish a charitable account maintained and managed by the MIT Investment Management Company, from which distributions may be made to MIT as well as to other charitable organizations. For Tahil and Wrenn, the speed with which DAF funds may be deployed came into play at a critical time: in the spring of 2020, they made a DAF distribution to the lab of Professor J. Christopher Love, the Raymond A. and Helen E. St. Laurent Chair in Chemical Engineering, to support the lab’s work on an affordable covid-19 vaccine.
A global view of the environment and health. The couple gives back to MIT in a variety of ways, including a fellowship to support graduate students who are conducting research to improve the environment through scientific, engineering, or public policy solutions. Tahil especially appreciates MIT’s research regarding the environment and medicine. “MIT is contributing to a better world by bringing its holistic, multidisciplinary approach to problems in a large variety of fields,” he says.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.